When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn. Artificial intelligence (AI) has long promised ...

In September, for example, the company signed an agreement with US start-up Valo Health to apply its AI-powered drug discovery engine to find new therapies for cardiometabolic diseases ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In the Southwest United States, bird migrations are shifting as global temperatures warm. Gustavo Martіnez Contreras takes us to the Bosque del Apache National Wildlife Refuge in the state of New ...

Jan. 15, 2025 — Research has established a clear link between racial and ethnic disparities in maternal heart health and higher risks of preterm birth, preeclampsia and cardiovascular issues for ...

Jan. 21, 2025 — When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as ...

As some people return to what's left of their homes after the Los Angeles-area wildfires, experts are warning about possible dangers of the ash that's left behind The Latest A push to reform the ...

In this article, we are going to take a look at where Clover Health Investments, Corp. (NASDAQ:CLOV) stands against the other stocks that are skyrocketing now. The market has started to favor ...

Billed as more than 10 times the scale of previous endeavors, the Truveta Genome Project aims to ensure representation across ancestries, ethnicities, genders and other social drivers of health – and ...

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results.